Biotech · Private company · Santa Monica, CA, US
Symphony Biosciences, Inc.
Track this companyFree. Adds Symphony Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancerFiscal year 2025 · $987.9KNIH RePORTER 5R44CA281563-03 · fetched Nov 12, 2026
- Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancerFiscal year 2024 · $992.7KNIH RePORTER 4R44CA281563-02 · fetched Nov 12, 2026